Brandywine Oak Private Wealth LLC Sells 1,075 Shares of The Chemours Company (NYSE:CC)

Brandywine Oak Private Wealth LLC lessened its position in The Chemours Company (NYSE:CCFree Report) by 4.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 23,741 shares of the specialty chemicals company’s stock after selling 1,075 shares during the quarter. Brandywine Oak Private Wealth LLC’s holdings in Chemours were worth $401,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in CC. Blue Trust Inc. grew its position in Chemours by 166.9% during the 3rd quarter. Blue Trust Inc. now owns 1,169 shares of the specialty chemicals company’s stock valued at $26,000 after purchasing an additional 731 shares during the last quarter. Matrix Trust Co bought a new position in Chemours in the 3rd quarter worth $25,000. GAMMA Investing LLC lifted its holdings in shares of Chemours by 99.7% in the fourth quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock worth $26,000 after buying an additional 765 shares in the last quarter. Truvestments Capital LLC bought a new stake in Chemours in the 3rd quarter worth approximately $35,000. Finally, Brooklyn Investment Group purchased a new stake in Chemours during the 3rd quarter valued at $37,000. 76.26% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Barclays raised their target price on shares of Chemours from $21.00 to $23.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 5th. Truist Financial started coverage on Chemours in a research report on Tuesday, January 28th. They set a “buy” rating and a $27.00 price target for the company. The Goldman Sachs Group reduced their price target on shares of Chemours from $24.00 to $21.00 and set a “neutral” rating for the company in a research report on Tuesday, January 7th. Royal Bank of Canada reiterated an “outperform” rating and set a $25.00 price objective on shares of Chemours in a research report on Thursday, December 12th. Finally, Mizuho reduced their price target on shares of Chemours from $22.00 to $21.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 7th. Five equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $24.11.

Get Our Latest Stock Analysis on CC

Chemours Price Performance

NYSE CC opened at $18.67 on Thursday. The Chemours Company has a 12 month low of $15.10 and a 12 month high of $31.76. The company has a debt-to-equity ratio of 6.05, a current ratio of 1.73 and a quick ratio of 0.92. The company’s 50 day simple moving average is $18.89 and its 200 day simple moving average is $19.35. The firm has a market capitalization of $2.79 billion, a PE ratio of 37.33 and a beta of 1.81.

Chemours (NYSE:CCGet Free Report) last posted its quarterly earnings results on Monday, November 4th. The specialty chemicals company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.32 by $0.08. Chemours had a return on equity of 29.48% and a net margin of 1.34%. The company had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same period last year, the business earned $0.64 EPS. The business’s quarterly revenue was up .9% on a year-over-year basis. As a group, equities research analysts forecast that The Chemours Company will post 1.21 EPS for the current fiscal year.

Chemours Profile

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Further Reading

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCFree Report).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.